HPV-16 E6 peptide MHQKRTAMFQDPPQERPRKLPQLC was used as the immmunogen for the HPV-16 antibody.
Reacts with E6 protein of human papilloma virus type 16 (HPV-16). Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are strongly associated with cervical, vaginal, and vulvar malignancies. The antibody reacts very strongly with formalin-fixed, paraffin-embedded tissues containing HPV-16.
Clonality:
Monoclonal
Clone Designation:
[4B12]
Purity:
Protein G affinity
Form:
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Antibody Type:
Primary Antibody
Application Dilute:
Immunohistochemistry (FFPE): 1-2ug/ml
Application Notes:
Optimal dilution of the HPV-16 antibody should be determined by the researcher.
* VAT and and shipping costs not included. Errors and price changes excepted